While many people are aware of the unpleasant consequences of this condition, few know that it can be caused by a variety of underlying medications, including using a GLP-1 (glucagon-like peptide-1) agonist drug like Ozempic
Dado que Vision Healthcare Group tiene su sede en Blgica, la autoridad de control principal es: Gegevensbeschermingsautoriteit (GBA) / Autorit de Protection des Donnes (APD) Rue de la Presse 35, 1000 Bruselas, Blgica Sitio web: www.gegevensbeschermingsautoriteit.be | Tel.: +32 (0)2 274 48 00 Los usuarios en Alemania tambin pueden ponerse en contacto con la Landesbehrde (autoridad estatal de proteccin de datos) correspondiente
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial PMID: 37385280 Lancet
Administration burden ranges from twice daily to once weekly